Top 5 Stocks To Invest In 2021

Warren Buffett once said that when its comes to stocks, his “favorite holding period is forever.” Investors shouldn’t blindly apply that idea to all stocks, but holding the best stocks “forever” can mean the difference between a 10% gain and multi-bagger returns. Today, I’ll discuss three of my favorite long-term holdings, and why I don’t plan to sell them anytime soon.


I bought Amazon (NASDAQ:AMZN) back in the low $600s, and it now trades at above $1,700. Yet I plan to keep holding the stock, because its growth story seems more compelling than ever.

Image source: Getty Images.

Amazon generates most of its revenue from its online marketplaces in over a dozen countries. Amazon locks in those customers with Prime, its premium plan, which offers discounts, free shipping, streaming media, and other perks.

Top 5 Stocks To Invest In 2021: Nuveen Core Equity Alpha Fund(JCE)

Nuveen Core Equity Alpha Fund (the Fund) is a diversified closed-end management investment company. The Fund’s investment objective is to provide total return. The Fund seeks to achieve its investment objective primarily through long-term capital appreciation, and secondarily through income and gains. The Fund will invest in a portfolio of common stocks selected by employing a mathematical process designed by its sub-advisor, Enhanced Investment Technologies, LLC (INTECH), which seeks to provide risk-adjusted excess returns (alpha) above the S&P 500 Index (the Index), with an equal or lesser amount of relative investment risk. The Fund will, to a limited extent, write (sell) call options primarily on custom baskets of securities that seek to track the return of the Index. Its investment advisor is Nuveen Asset Management (NAM), a wholly owned subsidiary of Nuveen Investments, Inc.

The Fund will invest its managed assets in a portfolio of common stocks from among the 500 stocks comprising the Index as selected by INTECH (the Equity Portfolio). INTECH will construct and manage the Equity Portfolio employing its mathematical process. Nuveen Core Equity Alpha Fund seeks to invest approximately 95% of its managed assets in the Equity Portfolio. The Fund will invest at least 80% of its managed assets in the Equity Portfolio. In constructing the Equity Portfolio, INTECH will employ its Large Cap Core strategy. The Large Cap Core strategy targets risk-adjusted excess returns for the Equity Portfolio (as distinguished from the Fund) over the Index of 3% to 4% annually. The Equity Portfolio will consist of a diversified portfolio of 250 to 450 common stocks included in the Index.

Nuveen Core Equity Alpha Fund may invest up to 10% of its managed assets in securities of other open or closed-end investment companies (including exchange-traded funds (ETFs)) that invest primarily in securities of the types, in which the Fund may invest directly and that have a similar investment objective! as that of the Fund. In addition, the Fund may invest a portion of its managed assets in pooled investment vehicles (other than investment companies) that invest primarily in securities of the types, in which the Fund may invest directly. The Fund may write call options on stock indexes or ETFs. It may invest in securities that, at the time of investment, are illiquid (securities that are not readily marketable). The Fund’s Equity Portfolio will be invested in liquid equity securities selected from the Index.

Advisors’ Opinion:

  • [By Max Byerly]

    Shaker Financial Services LLC lessened its holdings in shares of Nuveen Core Equity Alpha (NYSE:JCE) by 70.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 46,154 shares of the company’s stock after selling 112,257 shares during the period. Shaker Financial Services LLC’s holdings in Nuveen Core Equity Alpha were worth $674,000 at the end of the most recent reporting period.

Top 5 Stocks To Invest In 2021: Forest City Realty Trust, Inc.(FCE.A)

Forest City Realty Trust, Inc., incorporated on May 29, 2015, is engaged in the ownership, development, management and acquisition of commercial, and residential real estate and land throughout the United States. The Company’s segments include the Commercial Group, Residential Group, Land Development Group and Corporate Activities. The Company’s core markets include Boston, Chicago, Dallas, Denver, Los Angeles, Philadelphia, and the greater metropolitan areas of New York City, San Francisco and Washington D.C. The Company holds all of its assets, and conducts all of its business, through the Operating Partnership, Forest City Enterprises, L.P. The Company holds and operates certain of its assets through one or more taxable real estate investment trust (REIT) subsidiaries (TRSs).

Commercial Group

The Commercial Group segment owns, develops, acquires and operates regional malls, specialty/urban retail centers, office and life science buildings, and mixed-use projects. The Commercial Group segment’s portfolio is in both urban and suburban locations in approximately 10 states and the District of Columbia. The Commercial Group focuses on markets where it develops complex projects, employing public and/or private partnerships. In its office development activities, the Company is primarily a build-to-suit developer that works with tenants to meet their requirements. The Company’s office development focuses primarily on mixed-use projects in urban developments, often built in conjunction with hotels and/or retail centers or as part of an office or life science campus. Its regional malls are developed in collaboration with anchor stores that own their facilities as an integral part of the mall structure.

Residential Group

The Residential Group segment owns, develops, acquires, leases and manages residential rental properties in over 20 states and the District of Columbia. The Company is engaged in apartment community development. Its residential portfolio inc! ludes middle-market apartments, upscale urban properties, re-use developments, for-sale condominium projects and subsidized senior housing.

Land Development Group

The Land Development Group segment acquires and sells both land and developed lots to residential, commercial and industrial customers at its Stapleton project in Denver, Colorado. The Stapleton project is a urban redevelopment with future entitlements, including apartments, retail and office space, as well as single family neighborhoods, where the Company sells residential lots to homebuilders. The Company controls the development opportunity at Stapleton through an option agreement. The Company owns over 400 acres of undeveloped land (including approximately 160 saleable acres) and a purchase option for approximately 570 acres at Stapleton.

Advisors’ Opinion:

  • [By Max Byerly]

    Piedmont Office Realty Trust (NYSE: FCE.A) and Forest City Realty Trust (NYSE:FCE.A) are both mid-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Top 5 Stocks To Invest In 2021: Chatham Lodging Trust (REIT)(CLDT)

Chatham Lodging Trust, incorporated on October 26, 2009, is a real estate investment trust (REIT) organized to invest primarily in premium-branded upscale extended-stay and select-service hotels. All of the Company’s assets are held by, and all of its operations are conducted through, Chatham Lodging, L.P (Operating Partnership). The Operating Partnership and its subsidiaries lease the Company’s hotels. The Company owns approximately 40 hotels with over 5,680 (unaudited) rooms located in 15 states in the United States and the District of Columbia.

The Company’s hotels include upscale extended-stay hotels that operate under the Residence Inn by Marriott brand (over 10 hotels) and Homewood Suites by Hilton brand (approximately nine hotels), as well as premium-branded select-service hotels that operate under the Courtyard by Marriott brand (over four hotels), the Hampton Inn or Hampton Inn and Suites by Hilton brand (over three hotels), the SpringHill Suites by Marriott brand (approximately two hotels), the Hilton Garden Inn by Hilton brand (over two hotels) and the Hyatt Place brand (approximately two hotels). The service and amenity offerings of a few of these hotels include complimentary breakfast, Internet access, local calls, in-room movie channels, and daily linen and room cleaning service. Its hotels are located in Billerica, Massachusetts; Bloomington, Minnesota; Brentwood, Tennessee; Dallas, Texas; Farmington, Connecticut; Maitland, Florida; Houston, Texas; Altoona, Pennsylvania; Washington, Pennsylvania; Holtsville, New York; Garden Grove, California; Exeter, New Hampshire; Denver, Colorado; Savannah, Georgia, and Vienna, Virginia, among others.

Advisors’ Opinion:

  • [By Shane Hupp]

    TheStreet cut shares of Chatham Lodging Trust (NYSE:CLDT) from a b rating to a c+ rating in a research report report published on Thursday morning.

  • [By Motley Fool Transcribers]

    Chatham Lodging Trust  (NYSE:CLDT)Q4 2018 Earnings Conference CallFeb. 25, 2019, 10:00 a.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


  • [By Garrett Baldwin]

    There’s no guesswork involved, and the best part is – it’ll only take you 10 minutes per day! Click here now to start this once-in-a-lifetime journey…

    Stocks to Watch Today: KHC, HD, JWN, M, AAPL
    Kraft Heinz Co. (NYSE: KHC) is still licking its wounds after an abysmal earnings report on Thursday and a weak 2019 outlook. The consumer goods giant is looking to reshape its business as consumer tastes continue to evolve. According to reports, the firm – backed heavily by Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A) – is considering a deal to sell its Maxwell House brand. Warren Buffett is also affecting shares of Apple Inc. (NASDAQ: AAPL). Although AAPL stock added 0.4% in pre-market hours, Buffett said he would not purchase more shares of the company stock at these levels. However, should AAPL stock pull back in the near future, the “Oracle of Omaha” would consider purchasing more. Earnings season may be winding down, but concerns about the U.S. brick-and-mortar retail industry are always high. This week, Home Depot Inc. (NYSE: HD), Nordstrom Inc. (NYSE: JWN), and Macy’s Inc. (NYSE: M) will report earnings from the holiday quarter. Look for earnings reports from American States Water Co. (NYSE: AWR), Chatham Lodging Trust (NYSE: CLDT), EPR Properties (NYSE: EPR), Etsy Inc. (NASDAQ: ETSY), Life Storage Inc. (NYSE: LSI), Mosaic Co. (NYSE: MOS), Oneok Inc. (NYSE: OKE), Potbelly Corp. (NASDAQ: PBPB), Preferred Apartment Communities Inc. (NYSE: APTS), Rent-A-Center Inc. (NASDAQ: RCII), Shake Shack Inc. (NYSE: SHAK), and Tenet Healthcare Corp. (NYSE: THC).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 5 Stocks To Invest In 2021: GlaxoSmithKline PLC(GSK)

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company’s wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company’s nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc has a collaboration agreements with Université de Sherbrooke and Pfizer Inc.; development agreement, and R and D collaboration with Propeller Health; and collaboration and license agreement with Idera pharmaceuticals, Inc. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.

Advisors’ Opinion:

  • [By ]

    GlaxoSmithKline (NYSE: GSK) has fought for its asthma drug Advair, including the patented inhaler, for a few years now. Now, however, it seems to be finally facing off against generic competition. Just a month ago, on February 8, GSK announced that it plans to make an “authorized generic” version of Advair available. This is likely in a response to the FDA approving the first generic version of Advair on January 30, and an attempt to save at least some of the $1.4 billion in annual sales.

  • [By Ethan Ryder]

    TRADEMARK VIOLATION NOTICE: “GlaxoSmithKline plc (GSK) Shares Bought by Usca Ria LLC” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at

Top 5 Stocks To Invest In 2021: BioPharmX Corporation(BPMX)

BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women’s health, dermatology, and otolaryngology markets. The company offers prescription, over-the-counter (OTC), and supplement products in oral, topical, inhalant, and/or injectable forms. It provides VI2OLET iodine, an OTC dietary supplement molecular iodine tablet that promotes overall breast health and for the alleviation of benign breast pain associated with fibrocystic breast condition. The company’s clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a non-lipophilic topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician’s practices, including OB-Gyn’s, dermatologists, and general practioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Biopharmx Corp (NYSEAMERICAN:BPMX) were up 4.8% during mid-day trading on Tuesday . The stock traded as high as $0.22 and last traded at $0.20. Approximately 32,497 shares were traded during trading, a decline of 100% from the average daily volume of 8,266,355 shares. The stock had previously closed at $0.21.

Leave a Reply

Your email address will not be published. Required fields are marked *